LTR Pharma Limited (AU:LTP) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LTR Pharma Limited has announced the issuance of 300,000 new options set to expire on December 2, 2028. These unquoted securities are part of an employee incentive scheme and will not be listed on the ASX. This move reflects the company’s strategy to incentivize its workforce and potentially strengthen its market position.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.